Výsledky vyhledávání - "Esteban Ribera"

Akademický článek

Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab

Publikováno v: Nature Communications, Vol 10, Iss 1, Pp 1-15 (2019)

Here, the authors identify B lymphocyte antigen CD20 as a marker for HIV-infected T cells and provide evidence for the potential use of anti-CD20 antibodies in combination with latency reversing agents for depletion of viral reactivated CD4 T cells i

Externí odkaz: https://doaj.org/article/704040ec0d7d48cf90855591b8bb7358

Zobrazit plný text záznamu

Akademický článek

Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.

Publikováno v: PLoS ONE, Vol 16, Iss 4, p e0249515 (2021)

BackgroundSince 1996, the standard of care (SOC) therapy for HIV treatment has consisted of a backbone of two nucleoside analogue reverse transcriptase inhibitors (NRTI) paired with a third agent. Use of two-drug combinations (2DC) has been considere

Externí odkaz: https://doaj.org/article/a21ffaa9fa9b4ef6a70b618007f4be3a

Zobrazit plný text záznamu

Plný text ve formátu HTML

Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial

Autor: Mª Queralt Gorgas, Benito Almirante, Alfonso Ayora, Andrés Antón, Juliana Esperalba, Xavier Vidal, Cristina Aguilera, Esteban Ribera, Manuel Alonso, Antònia Agustí, Elena Guillén, Meritxell Espuga, Cristina Andrés

Publikováno v: Enfermedades Infecciosas y Microbiología Clínica
Enfermedades Infecciosas Y Microbiologia Clinica

Objectives To assess the efficacy and safety of hydroxychloroquine (HCQ) compared with no treatment in healthcare workers with mild SARS-CoV-2 infection. Methods Prospective, non-randomized study. All health professionals with confirmed COVID-19 betw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0befdf6bfe28ffffe9545aa87b021184
https://doi.org/10.1016/j.eimce.2020.10.015

Zobrazit plný text záznamu

Akademický článek

Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations.

Autor: Judith Grau-Expósito, Laura Luque-Ballesteros, Jordi Navarro, Adrian Curran, Joaquin Burgos, Esteban Ribera, Ariadna Torrella, Bibiana Planas, Rosa Badía, Mario Martin-Castillo, Jesús Fernández-Sojo, Meritxell Genescà, Vicenç Falcó, Maria J Buzon

Publikováno v: PLoS Pathogens, Vol 15, Iss 8, p e1007991 (2019)

Latency reversal agents (LRAs) have proven to induce HIV-1 transcription in vivo but are ineffective at decreasing the size of the latent reservoir in antiretroviral treated patients. The capacity of the LRAs to perturb the viral reservoir present in

Externí odkaz: https://doaj.org/article/2bef2fdb6c7348eda2f7cd05b56e89f2

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients

Autor: Judith Grau-Expósito, Carla Serra-Peinado, Lucia Miguel, Jordi Navarro, Adrià Curran, Joaquin Burgos, Imma Ocaña, Esteban Ribera, Ariadna Torrella, Bibiana Planas, Rosa Badía, Josep Castellví, Vicenç Falcó, Manuel Crespo, Maria J. Buzon

Publikováno v: mBio, Vol 8, Iss 4 (2017)

ABSTRACT Cells that actively transcribe HIV-1 have been defined as the “active viral reservoir” in HIV-infected individuals. However, important technical limitations have precluded the characterization of this specific viral reservoir during both

Externí odkaz: https://doaj.org/article/1c707eeefab54988a64553436d0814f0

Zobrazit plný text záznamu

Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment

Autor: Antonio Antela, Maria Romina Rivero, Lourdes Domínguez-Domínguez, José-Antonio Iribarren, Rafael Rubio, Mª Remedios Aleman, Adolfo Muñoz, Vicente Estrada, Esteban Ribera, Inmaculada Jarrín, Santiago Moreno, Otilia Bisbal, Marta Rava

Publikováno v: AIDS. 35:1283-1293

The aim of this study was to examine the impact of late presentation (CD4+ cell count350 cells/μl or an AIDS-defining event) on effectiveness and safety of initial antiretroviral therapy (ART) and to evaluate whether treatment response depends on fi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e41a64fcb378ea1dcf6cac344fa0d2d3
https://doi.org/10.1097/qad.0000000000002891

Zobrazit plný text záznamu

Akademický článek

Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.

Publikováno v: PLoS ONE, Vol 11, Iss 10, p e0164455 (2016)

Based on data from clinical practice, we evaluated the effectiveness and safety of switching to abacavir/lamivudine plus rilpivirine (ABC/3TC+RPV) treatment in virologically suppressed HIV-1-infected patients.We performed a multicenter, non-controlle

Externí odkaz: https://doaj.org/article/103689b34cd147e9826554a11e0335f9

Zobrazit plný text záznamu

Incidence of malignancy in a Spanish cohort of patients infected by the human immunodeficiency virus

Autor: Joaquin Burgos, Jordi Navarro, Berta Raventós, Adria Curran, Mario Martin-Castillo, Jorge García, Esperanza Cañas-Ruano, Vicenç Falcó, Esteban Ribera, Paula Suanzes

Publikováno v: Medicina Clínica (English Edition). 155:288-294

A higher incidence of malignancies has been described in patients with HIV infection compared to the general population.Observational retrospective study in patients with HIV infection followed up at the Vall d'Hebron University Hospital (Barcelona,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec2c83dfdbc80a0d5ccc4678ceb5ecd6
https://doi.org/10.1016/j.medcle.2019.12.006

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání